The relationship of patient age to the pathobiology of the clonal myeloid diseases
- 1 April 2004
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 31 (2) , 185-197
- https://doi.org/10.1053/j.seminoncol.2003.12.029
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Conservative treatment for patients over 80 years with acute myelogenous leukemiaAmerican Journal of Hematology, 2002
- Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213Leukemia, 2002
- Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemiaLeukemia, 2002
- Granulocyte–macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndromeLeukemia, 2002
- The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trialBlood, 2001
- Cytosine Arabinoside, Idarubicin and Divided Dose Etoposide for the Treatment of Acute Myeloid Leukemia in Elderly PatientsLeukemia & Lymphoma, 2001
- Treatment of newly‐diagnosed acute myelogenous leukaemia in patients aged 80 years and aboveBritish Journal of Haematology, 1996
- Prognostic Factors in Elderly Patients with Acute Myeloid LeukaemiaLeukemia & Lymphoma, 1994
- Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patientsBritish Journal of Haematology, 1994
- Age‐related incidence and other epidemiological aspects of myelodysplastic syndromesBritish Journal of Haematology, 1992